
Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated January 19, 2024, titled "Glenmark Life Sciences Signs Master Supply Agreement with a leading Japanese innovator pharmaceutical company".
Filed with NSE ·

Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated January 19, 2024, titled "Glenmark Life Sciences Signs Master Supply Agreement with a leading Japanese innovator pharmaceutical company".
6ix hasn’t read this filing yet.
Alivus Life Sciences Ltd on 6ix
Follow Alivus Life Sciences into a list and get an email when it puts out news.
Follow Alivus Life Sciences